Andere talen OLIK HLDG

Aandelen

OLK

US6807101000

Kantoorapparatuur

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 09-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
26,08 ^USD	+0,31%		-.--%	+3,70%

16/09	Thermo Fisher zal waarschijnlijk groeiplan bijwerken, focus op bedrijfslijnen, diensten, zegt UBS	MT
27/07	Thermo Fisher Scientific: opent het bal in de biotech met veel grandeur

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Thermo Fisher Likely to Update Growth Plan, Focus on Business Lines, Services, UBS Says	16/09
Thermo Fisher apre le danze del biotech con il botto	27/07
Thermo Fisher: Besser geht's kaum	26/07
Thermo Fisher opens the biotech ball with a bang	25/07
Thermo Fisher ouvre le bal dans la biotech en grande pompe	25/07
Notice to attend the Extra General Meeting of Olink Holding AB (publ)	11/07
Olink Holding AB(NasdaqGM:OLK) dropped from S&P Global BMI Index	11/07
Thermo Fisher Scientific Completes Acquisition of Olink	10/07
Olink Holding AB(NasdaqGM:OLK) dropped from NASDAQ Composite Index	10/07
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others.	10/07
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer	08/07
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher	08/07
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024	05/07
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery	03/07
Notice to attend the Extra General Meeting of Olink Holding AB (publ)	11/06
Notice to attend the Extra General Meeting of Olink Holding AB (publ)	11/06
Olink Target 48 Immune Surveillance Panel, the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	07/06
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence	06/06
Olink® Target 48 Immune Surveillance Panel ? the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	06/06
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Olink Holding's Q1 Net Loss Widens, Revenue Rises	13/05
Olink reports first quarter 2024 financial results	13/05
Olink Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen OLIK HLDG

Aandelen

OLK

US6807101000

Kantoorapparatuur

Andere talen

Filters